<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>According to a new, unifying view of the pathogenesis of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> and related syndromes, signs and symptoms <z:hpo ids='HP_0000001'>all</z:hpo> arise from localized primary venous <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, with effects of venous <z:hpo ids='HP_0000822'>hypertension</z:hpo> transmitted to nearby areas via persisting communicating venous passageways and compensatory collateral venous channels </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001052'>Port-wine stains</z:hpo> result from a <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disorder</z:e> rather than a neural disorder </plain></SENT>
<SENT sid="2" pm="."><plain>Symptoms depend upon the extent and location of the venous <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>This hypothesis is supported by published data and by original observations and Doppler ultrasonographic studies of orbital venous flow in patients with the <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This new understanding of underlying pathophysiology also elucidates the mechanism for tissue <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>Therapies aimed at obliterating <z:hpo ids='HP_0001052'>port-wine stains</z:hpo> to minimize the cosmetic blemish will reduce collateral venous blood-flow passageways </plain></SENT>
<SENT sid="6" pm="."><plain>In some instances, this reduction may worsen blood stasis within the brain and potentially exacerbate neurologic symptoms </plain></SENT>
</text></document>